Liquidia Technologies (LQDA) Competitors $26.84 -0.46 (-1.68%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$26.92 +0.09 (+0.32%) As of 08/22/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LQDA vs. STVN, IRTC, GKOS, BLCO, TMDX, SLNO, NVST, LIVN, WRBY, and INSPShould you be buying Liquidia Technologies stock or one of its competitors? The main competitors of Liquidia Technologies include Stevanato Group (STVN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry. Liquidia Technologies vs. Its Competitors Stevanato Group iRhythm Technologies Glaukos Bausch + Lomb TransMedics Group Soleno Therapeutics Envista LivaNova Warby Parker Inspire Medical Systems Stevanato Group (NYSE:STVN) and Liquidia Technologies (NASDAQ:LQDA) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation. Is STVN or LQDA more profitable? Stevanato Group has a net margin of 11.73% compared to Liquidia Technologies' net margin of -732.17%. Stevanato Group's return on equity of 10.34% beat Liquidia Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Stevanato Group11.73% 10.34% 6.21% Liquidia Technologies -732.17%-232.96%-60.81% Do analysts rate STVN or LQDA? Liquidia Technologies has a consensus price target of $32.11, indicating a potential upside of 19.64%. Given Liquidia Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Liquidia Technologies is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.83Liquidia Technologies 1 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.00 Does the media favor STVN or LQDA? In the previous week, Liquidia Technologies had 9 more articles in the media than Stevanato Group. MarketBeat recorded 12 mentions for Liquidia Technologies and 3 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.21 beat Liquidia Technologies' score of 0.29 indicating that Stevanato Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Liquidia Technologies 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, STVN or LQDA? Stevanato Group has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Comparatively, Liquidia Technologies has a beta of 0.14, meaning that its share price is 86% less volatile than the S&P 500. Which has preferable earnings and valuation, STVN or LQDA? Stevanato Group has higher revenue and earnings than Liquidia Technologies. Liquidia Technologies is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStevanato Group€1.19B5.71€127.45M€0.5441.70Liquidia Technologies$14M165.05-$130.39M-$1.70-15.79 Do insiders & institutionals believe in STVN or LQDA? 64.5% of Liquidia Technologies shares are held by institutional investors. 0.7% of Stevanato Group shares are held by insiders. Comparatively, 26.5% of Liquidia Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryStevanato Group beats Liquidia Technologies on 9 of the 17 factors compared between the two stocks. Get Liquidia Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LQDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LQDA vs. The Competition Export to ExcelMetricLiquidia TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.35B$3.11B$5.75B$9.62BDividend YieldN/A2.23%4.40%4.10%P/E Ratio-15.7921.1431.2526.05Price / Sales165.05345.39433.91193.97Price / CashN/A43.1937.7358.48Price / Book149.118.129.536.61Net Income-$130.39M-$54.72M$3.26B$265.65M7 Day Performance3.43%2.62%2.13%2.03%1 Month Performance51.21%2.68%2.80%-0.31%1 Year Performance169.21%10.93%30.68%19.06% Liquidia Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LQDALiquidia Technologies3.5293 of 5 stars$26.84-1.7%$32.11+19.6%+178.7%$2.35B$14M-15.7950STVNStevanato Group1.8092 of 5 stars€22.50-0.5%N/A+20.9%€6.81B€1.19B41.675,521Positive NewsIRTCiRhythm Technologies1.316 of 5 stars$157.93-1.7%$157.30-0.4%+142.2%$5.16B$591.84M-53.902,000News CoverageAnalyst ForecastInsider TradeGKOSGlaukos4.7558 of 5 stars$89.47-0.4%$127.42+42.4%-27.6%$5.15B$383.48M-54.22780Positive NewsAnalyst RevisionBLCOBausch + Lomb1.697 of 5 stars$14.49-0.4%$15.56+7.4%-6.7%$5.15B$4.79B-18.5713,500TMDXTransMedics Group2.8394 of 5 stars$125.65-1.5%$123.00-2.1%-30.9%$4.35B$441.54M65.10210News CoveragePositive NewsSLNOSoleno Therapeutics4.5682 of 5 stars$68.09-4.9%$114.30+67.9%+41.1%$3.81BN/A-16.4530News CoverageAnalyst ForecastAnalyst RevisionNVSTEnvista3.8405 of 5 stars$20.75+0.5%$20.92+0.9%+20.6%$3.43B$2.51B64.8312,300LIVNLivaNova1.713 of 5 stars$53.27-0.8%$59.29+11.3%+21.4%$2.93B$1.25B-13.692,900News CoveragePositive NewsAnalyst ForecastWRBYWarby Parker2.2773 of 5 stars$27.38+0.9%$24.06-12.1%+94.9%$2.85B$771.32M-391.093,780Analyst UpgradeINSPInspire Medical Systems4.9394 of 5 stars$88.28+0.6%$165.62+87.6%-48.6%$2.60B$802.80M51.031,246News CoveragePositive NewsShort Interest ↓ Related Companies and Tools Related Companies Stevanato Group Competitors iRhythm Technologies Competitors Glaukos Competitors Bausch + Lomb Competitors TransMedics Group Competitors Soleno Therapeutics Competitors Envista Competitors LivaNova Competitors Warby Parker Competitors Inspire Medical Systems Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LQDA) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access